Literature DB >> 22710039

The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.

Michael T Jaklitsch1, Francine L Jacobson, John H M Austin, John K Field, James R Jett, Shaf Keshavjee, Heber MacMahon, James L Mulshine, Reginald F Munden, Ravi Salgia, Gary M Strauss, Scott J Swanson, William D Travis, David J Sugarbaker.   

Abstract

OBJECTIVE: Lung cancer is the leading cause of cancer death in North America. Low-dose computed tomography screening can reduce lung cancer-specific mortality by 20%.
METHOD: The American Association for Thoracic Surgery created a multispecialty task force to create screening guidelines for groups at high risk of developing lung cancer and survivors of previous lung cancer.
RESULTS: The American Association for Thoracic Surgery guidelines call for annual lung cancer screening with low-dose computed tomography screening for North Americans from age 55 to 79 years with a 30 pack-year history of smoking. Long-term lung cancer survivors should have annual low-dose computed tomography to detect second primary lung cancer until the age of 79 years. Annual low-dose computed tomography lung cancer screening should be offered starting at age 50 years with a 20 pack-year history if there is an additional cumulative risk of developing lung cancer of 5% or greater over the following 5 years. Lung cancer screening requires participation by a subspecialty-qualified team. The American Association for Thoracic Surgery will continue engagement with other specialty societies to refine future screening guidelines.
CONCLUSIONS: The American Association for Thoracic Surgery provides specific guidelines for lung cancer screening in North America.
Copyright © 2012. Published by Mosby, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22710039     DOI: 10.1016/j.jtcvs.2012.05.060

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  193 in total

1.  The impact of radiologists' expertise on screen results decisions in a CT lung cancer screening trial.

Authors:  Marjolein A Heuvelmans; Matthijs Oudkerk; Pim A de Jong; Willem P Mali; Harry J M Groen; Rozemarijn Vliegenthart
Journal:  Eur Radiol       Date:  2014-11-04       Impact factor: 5.315

2.  Pros: long-term CT scan follow-up should be the standard of care in patients who are curatively treated for an early-stage non-small cell lung cancer.

Authors:  Waël C Hanna
Journal:  Transl Lung Cancer Res       Date:  2015-08

3.  Performance of ultralow-dose CT with iterative reconstruction in lung cancer screening: limiting radiation exposure to the equivalent of conventional chest X-ray imaging.

Authors:  Adrian Huber; Julia Landau; Lukas Ebner; Yanik Bütikofer; Lars Leidolt; Barbara Brela; Michelle May; Johannes Heverhagen; Andreas Christe
Journal:  Eur Radiol       Date:  2016-01-26       Impact factor: 5.315

Review 4.  New techniques for assessing response after hypofractionated radiotherapy for lung cancer.

Authors:  Sarah A Mattonen; Kitty Huang; Aaron D Ward; Suresh Senan; David A Palma
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

5.  Imaging Surveillance for Surgically Resected Stage I Non-Small Cell Lung Cancer: Is More Always Better?

Authors:  Melanie Subramanian; Jingxia Liu; Caprice Greenberg; Jessica Schumacher; George J Chang; Timothy L McMurry; Amanda B Francescatti; Tara R Semenkovich; Jessica L Hudson; Bryan F Meyers; Varun Puri; Benjamin D Kozower
Journal:  J Thorac Cardiovasc Surg       Date:  2018-10-24       Impact factor: 5.209

6.  An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management.

Authors:  Christopher G Slatore; Nanda Horeweg; James R Jett; David E Midthun; Charles A Powell; Renda Soylemez Wiener; Juan P Wisnivesky; Michael K Gould
Journal:  Am J Respir Crit Care Med       Date:  2015-08-15       Impact factor: 21.405

7.  Can high-risk CT features suggest local recurrence after stereotactic body radiation therapy for lung cancer? A systematic review and meta-analysis.

Authors:  Tae-Hyung Kim; Sungmin Woo; Darragh F Halpenny; Yeon Joo Kim; Soon Ho Yoon; Chong Hyun Suh
Journal:  Eur J Radiol       Date:  2020-04-07       Impact factor: 3.528

8.  Complication Rates and Downstream Medical Costs Associated With Invasive Diagnostic Procedures for Lung Abnormalities in the Community Setting.

Authors:  Jinhai Huo; Ying Xu; Tommy Sheu; Robert J Volk; Ya-Chen Tina Shih
Journal:  JAMA Intern Med       Date:  2019-03-01       Impact factor: 21.873

Review 9.  Lung cancer screening-don't forget the chest radiograph.

Authors:  Johannes Gossner
Journal:  World J Radiol       Date:  2014-04-28

10.  Radiotherapy for a second primary lung cancer arising post-pneumonectomy: planning considerations and clinical outcomes.

Authors:  Sashendra Senthi; Cornelis J A Haasbeek; Frank J Lagerwaard; Wilko F Verbakel; Patricia F de Haan; Ben J Slotman; Suresh Senan
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.